AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Oxycodone cuts neuropathic pain in diabetics. (Double-Blind Study of 159 Patients).

Internal Medicine News

| November 15, 2002 | Evans, Jeff | COPYRIGHT 2002 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

BALTIMORE -- Controlled-release oxycodone relieves several types of neuropathic pain in patients with diabetes, reported Mark P. Jensen, Ph.D., of the University of Washington, Seattle, and his associates.

After 6 weeks of treatment in a randomized, double-blind study, 82 patients with type 1 or 2 diabetes who received controlled-release oxycodone had significantly more improvement on 6 of 10 types of pain measured by the Neuropathic Pain Scale (NPS), compared with 77 similar patients in a placebo group. The study, funded by Purdue Pharma LP, was presented in poster form at the annual meeting of the American Pain Society.

Patients in the oxycodone group had significant declines in the intense, sharp, hot, dull, unpleasant, and ...

Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA